Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

被引:2
|
作者
Van Gool, Stefaan W. [1 ]
Makalowski, Jennifer [1 ]
Kampers, Linde F. C. [1 ]
Van de Vliet, Peter [1 ]
Sprenger, Tobias [1 ]
Schirrmacher, Volker [1 ]
Stucker, Wilfried [1 ]
机构
[1] Immun Onkol Zent Koln, Hohenstaufenring 30-32, D-50674 Cologne, Germany
关键词
Glioblastoma; DCVax((R))-L; dendritic cell vaccines (DC vaccines); individualized multimodal immunotherapy (IMI); external control arm (ECA); MALIGNANT GLIOMA; TUMOR VACCINATION; THERAPY; SURVIVAL; TEMOZOLOMIDE;
D O I
10.21037/tcr-23-603
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2224 / 2228
页数:5
相关论文
共 50 条
  • [1] Bioaerosols - A milestone has been reached!
    Bioaerosole - Ein Etappenziel ist erreicht!
    [J]. Tesseraux, Irene, 1600, VDI Fachmedien GmBH & Co. KG (74):
  • [2] Neurological research and practice: the first milestone has been reached
    Werner Hacke
    [J]. Neurological Research and Practice, 3
  • [3] Neurological research and practice: the first milestone has been reached
    Hacke, Werner
    [J]. NEUROLOGICAL RESEARCH AND PRACTICE, 2021, 3 (01):
  • [4] MICROCOMPUTER CHESS - HAS IT REACHED A NEW MILESTONE
    CRACRAFT, S
    [J]. ICCA JOURNAL, 1987, 10 (01): : 49 - 51
  • [5] Dendritic Cell Vaccination for Glioblastoma Multiforme: Clinical Experience and Future Directions
    Dejaegher, Joost
    Solie, Lien
    De Vleeschouwer, Steven
    Van Gool, Stefaan W.
    [J]. 2014 6TH INTERNATIONAL ADVANCED RESEARCH WORKSHOP ON IN SILICO ONCOLOGY AND CANCER INVESTIGATION (IARWISOCI), 2014,
  • [6] Dendritic cell therapy in glioblastoma multiforme
    Nesselhut, J.
    Nesselhut, T.
    Chang, R.
    Marx, D.
    Brockmann, W.
    Wilke, I.
    Matthes, C.
    Lorenzen, D.
    Stuecker, W.
    Peters, H.
    Lueke, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
    Dejaegher, Joost
    Van Gool, Stefaan
    De Vleeschouwer, Steven
    [J]. IMMUNOTARGETS AND THERAPY, 2014, 3 : 55 - 66
  • [8] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Hunn, Martin K.
    Bauer, Evelyn
    Wood, Catherine E.
    Gasser, Olivier
    Dzhelali, Marina
    Ancelet, Lindsay R.
    Mester, Brigitta
    Sharples, Katrina J.
    Findlay, Michael P.
    Hamilton, David A.
    Hermans, Ian F.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 319 - 329
  • [9] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Martin K. Hunn
    Evelyn Bauer
    Catherine E. Wood
    Olivier Gasser
    Marina Dzhelali
    Lindsay R. Ancelet
    Brigitta Mester
    Katrina J. Sharples
    Michael P. Findlay
    David A. Hamilton
    Ian F. Hermans
    [J]. Journal of Neuro-Oncology, 2015, 121 : 319 - 329
  • [10] A FEASIBILITY STUDY OF INTRA-NODAL AUTOLOGOUS DENDRITIC CELL VACCINATION FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Fadul, Camilo
    Szczepiorkowski, Zbignew
    Rhodes, Harker
    Fisher, Jan
    Demidenko, Eugene
    Eskey, Clifford
    Harris, Robert
    Kingman, Linda
    Hartford, Alan
    Wishart, Heather
    Lewis, Lionel
    Carlson, Cheryl
    Webber, Susan
    Fischer, Dawn
    Pipas, J. Marc
    Erkmenn, Kadir
    Roberts, David W.
    Simmons, Nathan
    Barth, Richard
    Ernstoff, Marc
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 811 - 811